Literature DB >> 23474032

Bioinspired peptides as versatile nucleic acid delivery platforms.

Vijaya Gopal1.   

Abstract

Non-viral gene therapy approaches have strongly established the utility of peptides as integral constituents of delivery platforms devised for efficient transfer of therapeutic molecules into cells. Among these, cell-penetrating peptides (CPPs), encompassing a family of short peptide sequences and their chimeric derivatives, have gained versatility through the addition of de novo peptide ligands primarily to facilitate cell-specific nucleic acid delivery in vitro and in vivo. The review illustrates the structural requirements of a noteworthy peptide TAT-PTD and other derivatives chiefly to exemplify their implication in gene therapy. An overview of the emerging concept and recent explorations will be presented through unique examples which form a facet in nanotechnology-based cancer therapy. Finally the basis for the utility of CPPs in plants will be discussed in view of its biotechnological potential.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23474032     DOI: 10.1016/j.jconrel.2013.02.021

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  3 in total

Review 1.  Applications of RNA interference in the treatment of arthritis.

Authors:  Muhammad Farooq Rai; Hua Pan; Huimin Yan; Linda J Sandell; Christine T N Pham; Samuel A Wickline
Journal:  Transl Res       Date:  2019-07-10       Impact factor: 7.012

2.  Recombinant cell-permeable HOXA9 protein inhibits NSCLC cell migration and invasion.

Authors:  Seong-Lan Yu; Han Koo; Hoi Young Lee; Young Il Yeom; Dong Chul Lee; Jaeku Kang
Journal:  Cell Oncol (Dordr)       Date:  2019-01-29       Impact factor: 6.730

3.  Engineering biodegradable and multifunctional peptide-based polymers for gene delivery.

Authors:  Julie Shi; Joan G Schellinger; Suzie H Pun
Journal:  J Biol Eng       Date:  2013-10-24       Impact factor: 4.355

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.